{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:44:46Z","timestamp":1793943886209,"version":"4.8.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T00:00:00Z","timestamp":1671148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007393","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","award":["20836"],"award-info":[{"award-number":["20836"]}],"id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jaut.2022.102983","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T13:09:15Z","timestamp":1673528955000},"page":"102983","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["B cell-specific mAb\u2013siRNA conjugates improve experimental myasthenia"],"prefix":"10.1016","volume":"135","author":[{"given":"Naazneen","family":"Ibtehaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afrin","family":"Bahauddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxim","family":"Ivannikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Rytting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Jamaluddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuejin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaren","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry L.","family":"Haller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruksana","family":"Huda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2022.102983_bib1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrneurol.2016.44","article-title":"Myasthenia gravis - autoantibody characteristics and their implications for therapy","volume":"12","author":"Gilhus","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jaut.2022.102983_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/nyas.13522","article-title":"Myasthenia gravis: the role of complement at the neuromuscular junction","volume":"412","author":"Howard","year":"2018","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.jaut.2022.102983_bib3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/1941875210382918","article-title":"Myasthenic crisis","volume":"1","author":"Wendell","year":"2011","journal-title":"Neurohospitalist"},{"key":"10.1016\/j.jaut.2022.102983_bib4","article-title":"Incidence, mortality, and economic burden of myasthenia gravis in China: a nationwide population-based study","volume":"5","author":"Chen","year":"2020","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.jaut.2022.102983_bib5","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3389\/fimmu.2020.00240","article-title":"New approaches to targeting b cells for myasthenia gravis therapy","volume":"11","author":"Huda","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2022.102983_bib6","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/mus.25973","article-title":"B cells in the pathophysiology of myasthenia gravis","volume":"57","author":"Yi","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jaut.2022.102983_bib7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3233\/JND-170294","article-title":"New pathways and therapeutic targets in autoimmune myasthenia gravis","volume":"5","author":"Behin","year":"2018","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.jaut.2022.102983_bib8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41582-018-0110-z","article-title":"Immunotherapy in myasthenia gravis in the era of biologics","volume":"15","author":"Dalakas","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jaut.2022.102983_bib9","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.clim.2017.01.005","article-title":"High-dose BAFF receptor specific mAb-siRNA conjugate generates Fas- expressing B cells in lymph nodes and high-affinity serum autoantibody in a myasthenia mouse model","volume":"176","author":"Ibtehaj","year":"2017","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2022.102983_bib10","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.4049\/jimmunol.176.4.2074","article-title":"Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN","volume":"176","author":"Le Bon","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2022.102983_bib11","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1002\/eji.201343418","article-title":"Peritoneal cavity B-1a cells promote peripheral CD4+ T-cell activation","volume":"43","author":"Margry","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2022.102983_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005456","article-title":"Crucial role for BAFF-BAFF-R signaling in the survival and maintenance of mature B cells","volume":"4","author":"Rauch","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2022.102983_bib13","doi-asserted-by":"crossref","first-page":"807","DOI":"10.4049\/jimmunol.173.2.807","article-title":"B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells","volume":"173","author":"Ng","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2022.102983_bib14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1084\/jem.20031330","article-title":"BCMA is essential for the survival of long-lived bone marrow plasma cells","volume":"199","author":"O'Connor","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2022.102983_bib15","article-title":"Experimental autoimmune myasthenia gravis in the mouse","volume":"15","author":"Wu","year":"2013","journal-title":"Curr. Protoc. Im."},{"key":"10.1016\/j.jaut.2022.102983_bib16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jaut.2013.01.003","article-title":"Complement C2 siRNA mediated therapy of myasthenia gravis in mice","volume":"42","author":"Huda","year":"2013","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2022.102983_bib17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jneuroim.2015.03.004","article-title":"IgG1 deficiency exacerbates experimental autoimmune myasthenia gravis in BALB\/c mice","volume":"281","author":"Huda","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2022.102983_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.804113","article-title":"Histone deacetylase isoforms differentially modulate inflammatory and autoantibody responses in a mouse model of myasthenia gravis","volume":"12","author":"Bahauddin","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jaut.2022.102983_bib19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1074-7613(01)00126-1","article-title":"Type 1 interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo","volume":"14","author":"Le Bon","year":"2001","journal-title":"Immunity"},{"issue":"Suppl 1","key":"10.1016\/j.jaut.2022.102983_bib20","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1186\/1471-2105-10-S1-S33","article-title":"A structural interpretation of the effect of GC-content on efficiency of RNA interference","volume":"10","author":"Chan","year":"2009","journal-title":"BMC Bioinf."},{"issue":"1- 4862","key":"10.1016\/j.jaut.2022.102983_bib21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jneuroim.2012.11.003","article-title":"The increased expression of CD21 on AchR specified B cells in patients with myasthenia gravis","volume":"256","author":"Yin","year":"2013","journal-title":"J. Neuroimmunol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841122001913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841122001913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:30:23Z","timestamp":1760257823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841122001913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":21,"alternative-id":["S0896841122001913"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2022.102983","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"B cell-specific mAb\u2013siRNA conjugates improve experimental myasthenia","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2022.102983","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102983"}}